CompletedPhase 2

Epigallocatechin Gallate and Other Antural Compounds in HPV Infections

Italy178 participantsStarted 2023-11-01

Plain-language summary

The investigators enroll patients with a PAP-test cytology reporting LSIL or ASCUS. Pateitns undergo HPV-DNA test for screening. Patients are treated with Epigallocatechin galalte, hyaluronic acid, folic acid and Vitamin B12 by oral route. After three months of treatment PAP-test and HPV-DNA test will be repeated.

Who can participate

Age range20 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Positivity to HPV-DNA test * PAP-test reporting LSIL or ASCUS Exclusion Criteria: * HPV-related pathologies or complicances apart from LSIL or ASCUS * Diagnosis of cancer

What they're measuring

Positivity to HPV infection

Timeframe: 3 and 6 months

Trial details

NCT IDNCT06098456

SponsorCentro di Ricerca Clinica Salentino

Sponsor typeNETWORK

Study typeINTERVENTIONAL

Primary completion2024-05-15

View on ClinicalTrials.gov More Papilloma-induced Cervical Lesions trials